Clinical Trials Directory

Trials / Unknown

UnknownNCT02611414

Effectiveness of tDCS for the Treatment of Functional Dyspepsia

Effectiveness of Transcranial Direct Current Stimulation for the Treatment of Functional Dyspepsia: a Randomized Controlled Trial

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
Hospital Ernesto Dornelles · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Functional dyspepsia is a very common disorder of great challenge to clinical management. A therapeutic targets is up-regulation of visceral pain threshold. The transcranial direct current stimulation (tDCS) is a novel therapy that pursues these properties, besides its safety and easy adherence. There is a great need of new treatments for functional dyspepsia. There is no current study evaluating tDCS for this disease.

Detailed description

Functional dyspepsia is a high prevalent disease with substantial costs to health system. There are many available treatments, but disappointing results are reported in clinical trials. TDCS is a noninvasive, secure and painless technique of brain stimulation. It is delivered by a battery-operated device that transfers low intensity electrical current to all surface of the brain. Then there is a modulation of cortical excitability and influence on central neurological functions. It has been reported its efficacy for the treatment of many diseases such as depression and chronic pain. Impairment of central mechanisms of interpretation and threshold of pain are related to functional dyspepsia. Therefore, tDCS may benefit dyspeptic patients. This study is a double blind randomized controled trial to test tDCS effectiveness on functional dyspepsia. Seventy functional dyspeptic patients will be enrolled, being randomized to either tDCS or sham tDCS.

Conditions

Interventions

TypeNameDescription
DEVICEanodal tDCStDCS anodal stimulation over M1 area applied for 20 minutes at five consecutive days.
DEVICESham tDCStDCS sham stimulation over M1 applied for 20 minutes (with current turned off at 30 seconds) at five consecutive days.

Timeline

Start date
2016-01-01
Primary completion
2019-01-01
Completion
2020-01-01
First posted
2015-11-20
Last updated
2016-05-19

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02611414. Inclusion in this directory is not an endorsement.